Results 231 to 240 of about 9,738,209 (281)

Influence of Scan Strategies in Electron Beam Powder Bed Fusion on Solidification, Microstructure, and High‐Temperature Compressive Properties of γ′‐Strengthened Inconel 738LC

Advanced Engineering Materials, EarlyView.
Experiments and thermophysical simulations were conducted to investigate the electron beam powder bed fusion electron beam (PBF‐EB/M) process for the γ′‐strengthened nickel‐based superalloy Inconel 738LC. The results demonstrate the impact of process‐induced microstructural variations on high‐temperature mechanical behavior, providing a basis for ...
Jan Niklas Petenati, Karthik Kumar Banku, Prasanth Bondi, Ivan Zhirnov, Yangyiwei Yang, Gordon Schmidt, Jürgen Christen, Georg Hasemann, Manja Krüger, Bai‐Xiang Xu, Bilal Gökce, Silja‐Katharina Rittinghaus   +11 more
wiley   +1 more source

Impact of MgO Additions on the Oxidation Resistance and Compression Behavior of Vanadium Alloys

Advanced Engineering Materials, EarlyView.
An increase in oxidation resistance at 600 °C is achieved for alloys containing more than 2.5 wt.% MgO. It has been established that, along with V2O5, MgO6V2, and Mg2O7V2 are formed, which are presumed to enhance oxidative stability. Furthermore, the possible transformation of Mg‐vanadates through reaction with CO2, which presumably occurs in this ...
Ievgen Solodkyi, Mathias Galetz, Georg Hasemann, Fabian Lanoy, Emma White, Manja Krüger   +5 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Good manufacturing practice

Quality, 2022
Kate Mccormick, Janet H. Sanders
openaire   +3 more sources

Good manufacturing practice

International Journal of Toxicology, 2013
We have established a current good manufacturing practice (GMP) manufacturing process to produce a nanoparticle suspension of 1,1′-methylenebis-4-[(hydroxyimino)methyl]pyridinium dimethanesulfonate (MMB4 DMS) in cottonseed oil (CSO) as a nerve agent antidote for a Phase 1 clinical trial.
Andrew P-Z, Clark, Hong, Dixon, Norma L, Cantu, Larry A, Cabell, Joe A, McDonough   +4 more
openaire   +3 more sources

Good manufacturing practice and viral safety

Blood Coagulation & Fibrinolysis, 1995
The concept of virus inactivation during the manufacture of blood products raises questions about possible recontamination of the product by the environment. A strict regime of good manufacturing practice (GMP) is mandatory. The guidelines originally issued by the World Health Organization (WHO), and now law in most countries, are an excellent basis ...
openaire   +2 more sources

good manufacturing practice (GMP)

2009
EC (IV): “The part of the pharmaceutical quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate for their intended use and as required by the product specification”; the FDA had 269 recalls in 1994, 248 in 1993, and 339 in 1992 for quality problems; according to the FDA, a firm must ...
openaire   +1 more source

Good manufacturing practices for the canning of tuna : Casing

1995
The section presents the good management practices on casing of canned tuna products.
Suwanrangsi, Sirilak, Keerathiviriyaporn, Suwimon, Sophonphong, Krissana, Briliantes, Supapun, Limpus, Leonard G.   +4 more
openaire   +4 more sources

Good Manufacturing Practices for Pharmaceuticals

2016
With global harmonization of regulatory requirements and quality standards and national and global business consolidations ongoing at a fast pace, pharmaceutical manufacturers, suppliers, contractors, and distributors are impacted by continual change.
openaire   +1 more source

Current Good Manufacturing Practices

2005
INTRODUCTION The need to meet the current Good Manufacturing Practices (cGMP) regulations is paramount in the pharmaceutical industry. Facilities that effectively incorporate the GMP requirements are easily licensed and thus bring the project on stream in a timely fashion.
openaire   +1 more source

Current good manufacturing practices

Transfusion, 1995
openaire   +2 more sources